Brief: Hologic Q3 Adjusted EBITDA USD 340.9 Million Vs. IBES Estimate USD 336.5 Million
Jul 30 (Reuters) - Hologic Q3 EPS USD 0.86. Q3 adjusted EPS USD 1.08 vs. IBES estimate USD 1.05 Q3 adjusted operating margin 30.1% Q3 gross margin 56.3% Q3 adjusted net income USD 244.1 million vs. IBES estimate USD 236.9 million Q3 adjusted gross margin 60.3% Q3 operating margin 24.9% Q3 revenue USD 1,023.8 million vs. IBES estimate USD 1,006 million outlook FY adjusted EPS USD 4.23-4.26 outlook FY EPS USD 2.56-2.59
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9